Roberta Sala

425 total citations
9 papers, 294 citations indexed

About

Roberta Sala is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Roberta Sala has authored 9 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Hematology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Roberta Sala's work include Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Roberta Sala is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Roberta Sala collaborates with scholars based in Italy, United States and Greece. Roberta Sala's co-authors include Franco Mandelli, Iole Cordone, Francesca Romana Mauro, Sabrina Leonetti Crescenzi, Raffaella Cerretti, Robert Foà, Edoardo Pescarmona, Diana Giannarelli, Roberto Bellucci and Paolo de Fabritiis and has published in prestigious journals such as Blood, Antibiotics and ChemMedChem.

In The Last Decade

Roberta Sala

8 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Sala Italy 6 216 158 107 67 48 9 294
Laura Fogliatto Brazil 9 132 0.6× 73 0.5× 92 0.9× 61 0.9× 25 0.5× 32 218
Paul J. Hengeveld Netherlands 9 90 0.4× 50 0.3× 121 1.1× 53 0.8× 59 1.2× 21 257
Juan Manuel Alonso‐Domínguez Spain 10 75 0.3× 26 0.2× 106 1.0× 30 0.4× 78 1.6× 40 242
Esperanza Lavilla Spain 8 36 0.2× 49 0.3× 82 0.8× 23 0.3× 65 1.4× 12 200
Christos Demosthenous Greece 8 64 0.3× 20 0.1× 77 0.7× 47 0.7× 71 1.5× 19 202
Chantana Polprasert Thailand 9 45 0.2× 87 0.6× 89 0.8× 77 1.1× 26 0.5× 42 226
Takanobu Morishita Japan 11 43 0.2× 48 0.3× 100 0.9× 42 0.6× 107 2.2× 37 268
Alison Yeomans United Kingdom 10 137 0.6× 89 0.6× 22 0.2× 72 1.1× 151 3.1× 20 339
Fotis Psarros Greece 9 159 0.7× 54 0.3× 31 0.3× 77 1.1× 26 0.5× 14 227
S Miyawaki Japan 6 99 0.5× 31 0.2× 216 2.0× 38 0.6× 164 3.4× 8 338

Countries citing papers authored by Roberta Sala

Since Specialization
Citations

This map shows the geographic impact of Roberta Sala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Sala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Sala more than expected).

Fields of papers citing papers by Roberta Sala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Sala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Sala. The network helps show where Roberta Sala may publish in the future.

Co-authorship network of co-authors of Roberta Sala

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Sala. A scholar is included among the top collaborators of Roberta Sala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Sala. Roberta Sala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Intra, Jari, Davide Carcione, Roberta Sala, et al.. (2023). Antimicrobial Resistance Patterns of Enterobacter cloacae and Klebsiella aerogenes Strains Isolated from Clinical Specimens: A Twenty-Year Surveillance Study. Antibiotics. 12(4). 775–775. 17 indexed citations
2.
3.
Skobridis, Konstantinos, Vassiliki Theodorou, Roberta Sala, et al.. (2009). Novel Imatinib Derivatives with Altered Specificity between Bcr–Abl and FMS, KIT, and PDGF Receptors. ChemMedChem. 5(1). 130–139. 17 indexed citations
4.
Bellucci, Roberto, Roberta Sala, Maria Stefania De Propris, Iole Cordone, & Paolo de Fabritiis. (1999). Interferon-α and Bcr-Abl Antisense Oligodeoxynucleotides in Combination Enhance the Antileukemic Effect and the Adherence of CML Progenitors to Preformed Stroma. Leukemia & lymphoma. 35(5-6). 471–481. 5 indexed citations
5.
Mauro, Francesca Romana, Robert Foà, Diana Giannarelli, et al.. (1999). Clinical Characteristics and Outcome of Young Chronic Lymphocytic Leukemia Patients: A Single Institution Study of 204 Cases. Blood. 94(2). 448–454. 13 indexed citations
6.
Mauro, Francesca Romana, Robert Foà, Diana Giannarelli, et al.. (1999). Clinical Characteristics and Outcome of Young Chronic Lymphocytic Leukemia Patients: A Single Institution Study of 204 Cases. Blood. 94(2). 448–454. 156 indexed citations
7.
Sala, Roberta, et al.. (1998). Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy. European Journal Of Haematology. 61(1). 14–20. 19 indexed citations
8.
Fabritiis, Paolo de, Maria Concetta Petti, Enrico Montefusco, et al.. (1998). BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase. Blood. 91(9). 3156–3162. 3 indexed citations
9.
Fabritiis, Paolo de, Maria Concetta Petti, Enrico Montefusco, et al.. (1998). BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase. Blood. 91(9). 3156–3162. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Fogliatto Breakdown of academic impact, for papers by Paul J. Hengeveld Breakdown of academic impact, for papers by Juan Manuel Alonso‐Domínguez Breakdown of academic impact, for papers by Esperanza Lavilla Breakdown of academic impact, for papers by Christos Demosthenous Breakdown of academic impact, for papers by Chantana Polprasert Breakdown of academic impact, for papers by Takanobu Morishita Breakdown of academic impact, for papers by Alison Yeomans Breakdown of academic impact, for papers by Fotis Psarros Breakdown of academic impact, for papers by S Miyawaki
Rankless by CCL
2026